Xconomy | Kendall Square - 
					Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date  ▴ Xconomist Location
Genzyme Pursues Multiple Sclerosis Market, Biogen Reports Progress in Same, BG Medicine Swallows $40 Million Cash Bolus, & More Life Sciences News Rebecca Zacks 07/23/08 Boston
Health 2.0 Firms in the Spotlight, Biogen Board in the Clear, Alnylam in Asia, & More Life Sciences News Rebecca Zacks 06/25/08 Boston
Alnylam Inks $93M Japanese Deal Rebecca Zacks 06/19/08 Boston
Blue Cross Blue Shield of Massachusetts Is First Insurance Company To Partner with Google Health Gregory T. Huang 06/12/08 Boston
Takeda and Alnylam Join Forces, Carl Icahn Makes His Case, New England Biotech is Hot (Duh), & More Life Sciences News Rebecca Zacks 05/29/08 Boston
Alnylam Inks $1 Billion Deal with Takeda Gregory T. Huang 05/27/08 Boston
Lies, Damned Lies, and Statistics: The Definitive Rundown on New England Biotech Gregory T. Huang 05/23/08 Boston
Gotuit and Lifetime Let Viewers Call the Shots Erik Mellgren 05/20/08 Boston
Codon Devices to Engineer Protein Drug for Merrimack Pharmaceuticals Erik Mellgren 04/16/08 Boston
ImmunoGen Scores $1.5M From Biogen Idec Rebecca Zacks 02/04/08 Boston
Genzyme Places Big Bet on Antisense RNA With Isis Deal Rebecca Zacks 01/08/08 Boston
Biogen Inks $380 Million Deal With Swiss Company Rebecca Zacks 11/20/07 Boston
Page 1 of 1
    

Business, life sciences, and technology news — covering Boston, Seattle, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.